Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer
Research conducted at L. Mathews and co-researchers has updated our knowledge about cancer
August 14th, 2008
"The pathways and key players that regulate parity-induced protection against breast cancer, conferred by estrogen (E) and progesterone (P), have not fully been explained. Interestingly, in rodents, high levels of circulating insulin-like growth factor-I (IGF-I) appear to block this parity-induced protection," scientists writing in the European Journal of Cancer Prevention report. "Using an in-vitro mouse mammary gland whole organ culture system, we investigated the mechanisms by which IGF-I affects the protective effects of E + P. Earlier studies have demonstrated that important changes induced by parity include both the enhanced sensitivity to p53 activation,...
Source: Women's Health Weekly (2008-08-14)
|
